SAN DIEGO - Maravai LifeSciences, Inc. (NASDAQ: MRVI), a $796 million market cap company known for supplying life science reagents and services, has announced the acquisition of intellectual property ...

Marvai LifeSciences has acquired assets and intellectual property from Molecular Assemblies at undisclosed terms. Marvai, a San Diego company, said Tuesday that the acquisition would expand the ...

Maravai LifeSciences (MRVI) announced its acquisition of intellectual property and relevant assets from Molecular Assemblies, or MAI. The ...

EST Maravai Lifesciences (MRVI) jumps 6% to $5.85 after MAI IP acquisition announcementInvest with Confidence: Follow TipRanks' Top Wall ...

Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech ...

Zai Lab Limited today announced the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) to ZL-1310, a potential highly active first-in-class DLL3 antibody-drug conjugate ...

Enhance your stock picks with dividend metrics like per-share dividends, yield, frequency, payout ratios, and more.

WASHINGTON, Jan. 16, 2025 /PRNewswire/ -- The U.S. Food and Drug Administration's (FDA) proposed rule to make cigarettes and certain other combusted tobacco products minimally or nonaddictive by ...

Integral Molecular (integralmolecular.com) is the industry leader in creating and commercializing transformative technologies that advance the discovery of therapeutics against difficult protein ...

Check Out Our Latest Stock Report on Maravai LifeSciences Maravai LifeSciences Stock Performance NASDAQ:MRVI opened at $4.56 on Thursday. The firm has a 50-day moving average of $5.52 and a two ...

Prices shown are in the currency of the stock selected. For example, if a UK stock is chosen these figures are in sterling, if a US stock chosen then the figures shown are in dollars. Important ...